1-8 of 8
K Morris
Close
Sort by
Journal Articles

Dose-Dense Brentuximab Vedotin Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Is Highly Active for Second Line Treatment in Relapsed/Refractory Classical Hodgkin Lymphoma: Final Results of a Phase I/II Study

Ryan C. Lynch, MD, Ryan D. Cassaday, MD, Stephen D. Smith, MD, Jonathan R. Fromm, MD PhD, Andrew J. Cowan, MD, Edus H. Warren, MD PhD, Mazyar Shadman, MDMPH, Andrei R Shustov, MD, Brian G. Till, MD, Chaitra S. Ujjani, MD, Edward Libby, MD, Mary Philip, MDPhD, Hilary Coye, PA-C, Christen N. Martino, NP, Sandra Kanan, MSN, ARNP, Karolyn K. Morris, BA, Heather A. Rasmussen, BS, Sanaz Behnia, MD, Margaret E. Nartea, BS, Jenna M. Voutsinas, MPH, Ajay K. Gopal, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–18.
https://doi.org/10.1182/blood-2020-133763
Published: 2020
Journal Articles

Ibrutinib in Relapsed or Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma: Final Results from a Prospective Phase II Study

Solomon A. Graf, MD, Ryan D. Cassaday, MD, Karolyn K. Morris, BA, Sanaz Behnia, MD, Qian Vicky Wu, PhD, Jenna M. Voutsinas, MPH, Ryan C. Lynch, MD, Elizabeth Krakow, MD, Heather A. Rasmussen, BS, Thomas R. Chauncey, MD PhD, Sandra Kanan, MSN, ARNP, Lorinda A. Soma, MD, Stephen D. Smith, MD, Ajay K. Gopal, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1596.
https://doi.org/10.1182/blood-2019-126086
Published: 2019
Journal Articles

Ibrutinib Is Effective in Relapsed or Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma: Results from a Prospective Phase II Study

Solomon A. Graf, MD, Ryan D. Cassaday, MD, Karolyn K. Morris, Heather A. Rasmussen, BS, Pamela S. Becker, MD, Thomas R. Chauncey, MD PhD, Sandra Kanan, MSN, ARNP, Lorinda A. Soma, MD, Stephen D. Smith, MD, Ajay K. Gopal, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2954.
https://doi.org/10.1182/blood-2018-99-115476
Published: 2018
Journal Articles

Adult Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation, Fludarabine, and Thiotepa Conditioning

Sarah Anand, MD, Samantha Thomas, Kelly Corbet, Cristina Gasparetto, MD, Richard Lopez, MD, Gwynn D. Long, MD, Ashley K. Morris, PharmD, David A. Rizzieri, MD, Stefanie Sarantopoulos, MD PhD, Keith M Sullivan, MD, Anthony D. Sung, MD, Nelson J. Chao, MD, Mitchell E. Horwitz, MD
Journal: Blood
Blood (2016) 128 (22): 3395.
https://doi.org/10.1182/blood.V128.22.3395.3395
Published: 2016
Journal Articles

Gel point and fractal microstructure of incipient blood clots are significant new markers of hemostasis for healthy and anticoagulated blood

Phillip A. Evans, Karl Hawkins, Roger H. K. Morris, Naresh Thirumalai, Roger Munro, Lisa Wakeman, Matthew J. Lawrence, P. Rhodri Williams
Journal: Blood
Blood (2010) 116 (17): 3341–3346.
https://doi.org/10.1182/blood-2010-02-269324
Published: 2010
Journal Articles

Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells

Petter S. Woll, Julie K. Morris, Matt S. Painschab, Rebecca K. Marcus, Aimee D. Kohn, Travis L. Biechele, Randall T. Moon, Dan S. Kaufman
Journal: Blood
Blood (2008) 111 (1): 122–131.
https://doi.org/10.1182/blood-2007-04-084186
Published: 2008
Includes: Supplemental data
Journal Articles

Improved Analysis of Hematopoietic Engraftment by Non-Invasive In Vivo Bioluminescent Imaging of Transplanted Human Embryonic Stem Cell-Derived Hematopoietic Cells.

Jonathan L. Linehan, BS, Xinghui Tian, PhD, Julie K. Morris, BS, Dan S. Kaufman, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1270.
https://doi.org/10.1182/blood.V106.11.1270.1270
Published: 2005
Journal Articles

An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults

IT Magrath, C Janus, BK Edwards, R Spiegel, ES Jaffe, CW Berard, J Miliauskas, K Morris, R Barnwell
Journal: Blood
Blood (1984) 63 (5): 1102–1111.
https://doi.org/10.1182/blood.V63.5.1102.1102
Published: 1984